Long-Term Effectiveness and Drug Survival of Secukinumab in Vietnamese Patients with Psoriasis: Results from a Retrospective ENHANCE Study (vol 13, pg 465, 2023)

被引：0

作者：

Hao Trong Nguyen ^{[1
]}

Nhi Thi Uyen Pham ^{[1
]}

Tu Nguyen Anh Tran ^{[1
]}

Nguyen Nhat Pham ^{[1
]}

Yen Thi Bui ^{[2
]}

Thao Thi Phuong Vu ^{[1
]}

机构：

[1] Ho Chi Minh City Hosp Dermatovenereol, Ward Vo Thi Sau, 2 Nguyen Thong,Dist 3, Ho Chi Minh City, Vietnam

[2] Novartis Vietnam Co Ltd, Ho Chi Minh City 700000, Vietnam

来源：

DERMATOLOGY AND THERAPY | 2023年 / 13卷 / 11期

关键词：

D O I：

10.1007/s13555-023-01021-y

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：2927 / 2927

页数：1

共 50 条

[31] Secukinumab Demonstrated High Effectiveness in Vietnamese Patients with Moderate-To-Severe Plaque Psoriasis in a Real-World Clinical Setting: 16 Week Results from an Observational Study
Nguyen, Hao T.
Pham, Nhi T. U.
Tran, Tu N. A.
Nguyen, Nhuong T. T.
Vu, Thao T. P.
DERMATOLOGY AND THERAPY, 2021, 11 (05) : 1613 - 1621
[32] Long-term drug survival of secukinumab in real life in the era of novel biologics: a 5-year, retrospective study, including difficult-to-treat areas
Sotiriou, E.
Bakirtzi, K.
Vakirlis, E.
Papadimitriou, I.
Eftychidou, P.
Trifona, M.
Lallas, A.
Ioannides, D.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (08) : E626 - E627
[33] Long-term efficacy of secukinumab in Korean patients with moderate-to-severe plaque psoriasis in a real-world setting; A single-center, retrospective study
Park, J.
Lee, S.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S68 - S68
[34] Secukinumab demonstrated sustained retention and safety in a real-world setting in patients with moderate to severe plaque psoriasis: Long-term results from an interim analysis of the SERENA study
Augustin, Matthias
von Kiedrowski, Ralph
Rigopoulos, Dimitris
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB107 - AB107
[35] Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study
Fritzsching, Benedikt
Contoli, Marco
Porsbjerg, Celeste
Buchs, Sarah
Larsen, Julie Rask
Elliott, Lisa
Rodriguez, Mercedes Romano
Freemantle, Nick
LANCET REGIONAL HEALTH-EUROPE, 2022, 13
[36] factors associated with the prognosis and long-term survival of patients with metastatic lung adenocarcinoma: a retrospective analysis (vol 10, pg 2070, 2018)
Huang, Chen-Yang
Chen, Bo-Huan
Chou, Wen-Chi
Yang, Cheng-Ta
Chang, John Wen-Cheng
JOURNAL OF THORACIC DISEASE, 2018, 10 (07) : E604 - E604
[37] Long-term efficacy and safety of secukinumab in Japanese patients with moderate to severe plaque psoriasis: 3-year results of a double-blind extension study
Okubo, Yukari
Ohtsuki, Mamitaro
Morita, Akimichi
Yamaguchi, Masako
Shima, Tomohiro
Tani, Yumiko
Nakagawa, Hidemi
JOURNAL OF DERMATOLOGY, 2019, 46 (03): : 186 - 192
[38] The long-term survival of esophageal cancer in elderly patients: A multi-center, retrospective study from China
Li, Runhua
He, Yutong
Sun, Xibin
Wang, Ning
Zhang, Min
Wei, Kuangrong
Li, Huizhang
Dong, Peng
Du, Lingbin
Chen, Wanqing
CANCER MEDICINE, 2023, 12 (04): : 4852 - 4863
[39] Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)
Chiricozzi, Andrea
Megna, Matteo
Giunta, Alessandro
Carrera, Carlo Giovanni
Dapavo, Paolo
Balato, Anna
Malagoli, Piergiorgio
Mazzoccoli, Stella
Parodi, Aurora
Sabatino, Silvia
Buzzoni, Carlotta
Huang, Chu-Han
Narcisi, Alessandra
JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
[40] Real-world drug survival of Brodalumab, in patients with psoriasis switched from Ixekizumab: Results of a single centre retrospective study (BroSwitch)
Bethlem, Jolijn C.
Janssens, Jenny A. H. M.
Tjioe, Milan
JEADV CLINICAL PRACTICE, 2023, 2 (03): : 510 - 517

← 1 2 3 4 5 →